PNC Financial Services Group
EVMN

PNC Financial Services Group’s Evommune Inc EVMN Stock Holding History

PNC Financial Services Group’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22K Buy
+92
New +$2.14K ﹤0.01% 4805

Other funds holding EVMN

AP
Andera Partners Paris $206M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PNC Financial Services Group's EVMN Position: Q2 2026 in Review

PNC Financial Services Group opened a new position in Evommune Inc (EVMN) in Q2 2026: 92 shares worth $1.22K. The stake represents ﹤0.01% of the portfolio and ranks #4805 among its holdings.

21 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • PNC Financial Services Group held 92 shares of Evommune Inc worth $1.22K as of Q2 2026.
  • Evommune Inc was a new PNC Financial Services Group position in Q2 2026.
  • Evommune Inc made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4805 holding.
  • 21 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.